Cargando…

Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy

Detalles Bibliográficos
Autores principales:	Greinacher, Andreas, Langer, Florian, Schönborn, Linda, Thiele, Thomas, Haddad, Munif, Renné, Thomas, Rollin, Jerome, Gruel, Yves, Warkentin, Theodore E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052910/ https://www.ncbi.nlm.nih.gov/pubmed/34965704 http://dx.doi.org/10.3324/haematol.2021.280366

Ejemplares similares

Decline in Pathogenic Antibodies over Time in VITT
por: Schönborn, Linda, et al.
Publicado: (2021)

SARS-CoV-2 Infection in Patients with a History of VITT
por: Schönborn, Linda, et al.
Publicado: (2022)

Monoclonal and Oligoclonal Anti-PF4 Antibodies Mediate VITT
por: Singh, Bandana, et al.
Publicado: (2021)

The deglycosylated form of 1E12 inhibits platelet activation and prothrombotic effects induced by VITT antibodies
por: Vayne, Caroline, et al.
Publicado: (2022)

Longitudinal Aspects of VITT
por: Schönborn, Linda, et al.
Publicado: (2022)

The Deglycosylated Form of 1E12, a Monoclonal Anti-PF4 IgG, Strongly Inhibits Antibody-Triggered Cellular Activation in Vaccine-Induced Thrombotic Thrombocytopenia, and Is a Potential New Treatment for Vιττ
por: Vayne, Caroline, et al.
Publicado: (2021)

Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient
por: Schönborn, Linda, et al.
Publicado: (2022)

A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination
por: Handtke, Stefan, et al.
Publicado: (2021)

Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin
por: Singh, B, et al.
Publicado: (2021)

Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Greinacher, Andreas, et al.
Publicado: (2022)

Early recognition and treatment of pre-VITT syndrome after adenoviral vector-based SARS-CoV-2 vaccination may prevent from thrombotic complications: review of published cases and clinical pathway
por: Salih, Farid, et al.
Publicado: (2022)

Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources
por: Greinacher, Andreas, et al.
Publicado: (2022)

Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT
por: Kanack, Adam J., et al.
Publicado: (2022)

Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)—Insights from Clinical Cases, In Vitro Studies and Murine Models
por: Dabbiru, Venkata A. S., et al.
Publicado: (2023)

Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2
por: Thiele, Thomas, et al.
Publicado: (2021)

Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein
por: Greinacher, Andreas, et al.
Publicado: (2021)

Vaccine‐induced immune thrombotic thrombocytopenia (VITT) after SARS‐CoV‐2 vaccination: Two cases from Germany with unusual presentation
por: Edmonds, Rhea, et al.
Publicado: (2023)

Vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Warkentin, Theodore E.
Publicado: (2022)

COVID‐19 patients often show high‐titer non‐platelet‐activating anti‐PF4/heparin IgG antibodies
por: Brodard, Justine, et al.
Publicado: (2021)

Variable serotonin release assay pattern and specificity of PF4‐specific antibodies in HIT, and clinical relevance
por: Rollin, Jérôme, et al.
Publicado: (2022)

Monoclonal gammopathies
por: Tozzi, S
Publicado: (2010)

Alternative diagnosis to heparin-induced thrombocytopenia in two critically ill patients despite a positive PF4/heparin-antibody test
por: Hron, Gregor, et al.
Publicado: (2013)

Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Gabarin, Nadia, et al.
Publicado: (2022)

Persistence of Ad26.COV2.S‐associated vaccine‐induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies
por: Kanack, Adam J., et al.
Publicado: (2022)

The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance
por: Castillo, Jorge J., et al.
Publicado: (2021)

Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S
por: Huynh, Angela, et al.
Publicado: (2022)

Monoclonal gammopathy of “ocular” significance
por: Karakus, Sezen, et al.
Publicado: (2019)

Cutaneous manifestations of monoclonal gammopathy
por: Claveau, Jean-Sebastien, et al.
Publicado: (2022)

Monoclonal Gammopathy of Thrombotic Significance
por: Gkalea, Vasiliki, et al.
Publicado: (2023)

MONOCLONAL GAMMOPATHY OF CLINICAL SIGNIFICANCE
por: Bladé, J.
Publicado: (2023)

Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review
por: Warkentin, Theodore E., et al.
Publicado: (2022)

Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia
por: Giles, Jason B., et al.
Publicado: (2022)

Epidemiology of VITT
por: Pai, Menaka
Publicado: (2022)

Monoclonal gammopathy of clinical significance: in vivo demonstration of the anti-thrombotic effect of an acquired anti-thrombin antibody
por: Schell, Berenice, et al.
Publicado: (2020)

Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy
por: Szalat, R, et al.
Publicado: (2014)

Acute Kidney Injury in Monoclonal Gammopathies
por: Menè, Paolo, et al.
Publicado: (2021)

Urticarial rash with leukocytosis and monoclonal gammopathy
por: De, Devea R., et al.
Publicado: (2022)

Necrobiotic Xanthogranuloma as Sign of Monoclonal Gammopathy
por: Conforti, Claudio, et al.
Publicado: (2022)

Evidence for immunoglobulin-mediated vasculitis caused by monoclonal gammopathy in monoclonal gammopathy of unclear significance prompting oncologic treatment
por: Drerup, Christian, et al.
Publicado: (2019)

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
por: Leung, Nelson, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ekd59f881fsj2sfnaqnoai78b7